Cirrosis hepática criptogenética y mutaciones de factores protrombóticos, ¿una mera asociación?

Monereo Muñoz, María; Aguilera García, Selena Gala; Barreda Heusser, Raquel de la; González Arnay, Emilio; García-Hernández, Sonia; González Reimers, Emilio.
Rev. esp. enferm. dig ; 108(9): 588-591, sept. 2016.
Artículo en Español | IBECS (España) | ID: ibc-156136

Documentos relacionados

  1. FV and APC resistance: the plot thickens.
  2. Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.
  3. Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
  4. [Factor V Leiden mutation as a cause of venous thrombosis].
  5. Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.
  6. Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients.
  7. Cryptogenetic liver cirrhosis and prothrombotic mutations - A mere association?
  8. Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma.
  9. A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.
  10. Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis.